TEL AVIV, Israel, Jan. 16, 2019 /PRNewswire/ -- The world's leading cannabis researchers and scientists, ag-tech, pharma experts, regulators, investors, and entrepreneurs will share their knowledge about the burgeoning medical cannabis industry at CannaTech Panama, Panama's first ever international Summit for Accelerating Medical Cannabis Innovation.
The main event will take place February 12-13, 2019 at the Central Hotel in Casco Viejo, the capital's unique Old Quarter which is a UNESCO World Heritage Site.
The cannabis economy is the world's fastest growing industry, with an outstanding record of accomplishment in research and development and with significant contribution to a vast array of medical treatments. Interest in the Latin American cannabis market is currently exploding as legalization across the continent continues and patient interest expands exponentially.
The Summit will cover the most current industry topics including Science and Medicine, AgTech and Innovation, Business and Finance, and Policy and Regulation, curated with an emphasis on Latin America.
LATAM and International CannaTech Panama speakers include:
GIADHA AGUIRRE de CARCER, Founder & CEO, New Frontier Data
DR. MARIA-FERNANDA ARBOLEDA, Medical Director, Khiron Life Sciences Corp.
NIRIT BERNSTEIN, PHD, Senior Research Scientist, ARO, Volcani Institute, Israel
CHRIS BOLTON, COO and Founder, TheraCann International Benchmark Corporation, Panama
LORENA BELTRAN, Co-owner and Director of Operations, Endonatura Labs Mexico
DR. MICHAEL DOR, Chief Medical Officer, Ministry of Foreign Affairs, Israel
DR. ROBIN ELY, Founder and Director, Center for Integrative and Cannabis Medicine, USA
DR. JARIO ESPINIOZA, Founder, ILANS (Latin American Institute of Neurology and Nervous System)
LORNE GERTNER, Chairman & Co-Founder, Tokyo Smoke, Canada
BOB HOBAN, CEO & President, Hoban Law Group, USA
MATTHEW MURPHY, Vice President, Compliance and Security, Khiron Life Sciences
ALFREDO PASCUAL, International Analyst, Marijuana Business Daily
DEREK RIEDLE, Founder and Publisher, Civilized
CHRIS WALSH, Vice President, Editorial & Strategic Development, Marijuana Business Daily
"Latin America is a key and growing player in the cannabis industry. Medical cannabis is legal in 10 Latin American countries and that list is growing. Demand for medical cannabis among patients is rapidly expanding. Cannabis business interest in LATAM is exploding due to numerous factors including low cost of production and facilities as compared to North America and Europe. It is estimated that the region's cannabis market will be worth $12.7 billion in 2028 while the medical cannabis market is forecast to be worth $8.5 billion within the decade. I could not be prouder to bring CannaTech to Panama and work with like minded professionals who understand the immense global health and business potential of medical cannabis moving forward," said Saul Kaye, Founder and CEO and Founder of iCAN:Israel-Cannabis and CannaTech.
About iCAN: Israel-Cannabis
iCAN: Israel-Cannabis is a leading Israeli developer of cannabis-based formulations, clinical trials and cannabis testing. iCAN is committed to accelerate Israel's Canna-Technology industry, capitalizing on Israeli innovation and a leading cannabis regulatory environment to bring premier products to market. iCAN is powered by CannaTech, the premier international cannabis summit held annually in Tel Aviv, and around the world including London, Sydney, Hong Kong and now Panama in 2019. Click here to learn more about iCAN.
CannaTech is the only Medical Cannabis event of its kind with a global focus that offers senior industry leaders, medical and scientific experts, and new ventures the platform to come together, drive innovation, form partnerships and promote knowledge exchange.